Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancer investigators.
Cedars-Sinai announced today a $10 million gift to establish the Bernard and Maxine Platzer Lynn Family Memory and Healthy Aging Program in the Department of Neurology. The program will broaden the scope of age-related care at Cedars-Sinai—with a focus on healthy aging, patient independence, care coordination, and brain health.
Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it easier to predict if a person will have a heart attack.
Researchers have uncovered new information about how the area of the brain responsible for memory is triggered when the eyes come to rest on a face versus another object or image.
Cedars-Sinai orthopaedic experts will present their latest advances in treatments and research at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) in Chicago March 22-26, sharing innovations to improve the quality of patient care and diversify the ranks of surgeons.
As mask mandates disappear across the U.S., many are eager to return to pre-pandemic life. But scientists warn against letting down our guard too soon, pointing out that new variants could arise in the months ahead.
When Reverend Hannah Rhiza steers her Spiritual Care Cart through Cedars-Sinai Marina del Rey Hospital, it's hard not to notice. The tiered trolley for staff overflows with neat stacks of flavored teas and self-care notecards nestled among a lollipop topiary and flickering electric tea lights.
Investigators at Cedars-Sinai have identified a potential new therapy for COVID-19: a biologic substance created by reengineered human skin cells.
The brain is front and center during March, and experts from the Cedars-Sinai departments of Neurology & Neurosurgery are available for interviews about the latest research and treatments for neurological diseases and conditions, including multiple sclerosis, epilepsy and traumatic brain injuries.
Researchers have discovered two types of brain cells that play a key role in dividing continuous human experience into distinct segments that can be recalled later. The discovery provides new promise as a path toward development of novel treatments for memory disorders such as dementia and Alzheimer’s disease.
There are no ifs, ands or “butts” about it: March is Colorectal Cancer Awareness Month and a timely reminder to get screened for one of the deadliest—and most preventable—cancers.
Two years after the pandemic began, the virus that causes COVID-19 is becoming a little easier to live with, thanks to medical innovations.
Just a decade ago, patients with severe aortic stenosis—a narrowing of the heart’s main valve—were left with two options: undergo high-risk open-heart surgery or do nothing to treat their life-threatening condition.
Targeting a specific protein that is often overexpressed in prostate cancer can help prevent or delay the disease from spreading to other parts of the body, according to a study led by Cedars-Sinai Cancer investigators.
Kiranbir Josan, MD, a noninvasive clinical cardiologist, has joined the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai, ranked among the country’s best by U.S. News & World Report.
The highly contagious omicron variant of SARS-CoV-2 became the dominant strain in the United States in mid-December 2021, coinciding with a rise in hospitalizations of patients with COVID-19. Among those admitted during the omicron surge, vaccinated adults had less severe illness compared with unvaccinated adults and were less likely to land in intensive care, according to a new study by Cedars-Sinai and the Centers for Disease Control and Prevention (CDC).
Physician-scientists in the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence (AI) tool that can effectively identify and distinguish between two life-threatening heart conditions that are often easy to miss: hypertrophic cardiomyopathy and cardiac amyloidosis. The new findings were published in JAMA Cardiology.
Prominent gynecologic oncologist and surgeon B.J. Rimel, MD, recently was named medical director of the Cedars-Sinai Cancer Clinical Trials Office. She will serve as a medical liaison between clinical trial principal investigators and Cedars-Sinai Cancer leadership to ensure the quality of services provided to patients.
Cedars-Sinai has opened the Acoustic Neuroma and Lateral Skull Base Center, further expanding its expertise in treating patients with these noncancerous—but potentially life-altering—tumors.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
